Positive Results from Moderna's Mid-Stage Trial
1 Mins read
Moderna Inc.’s stock (MRNA) experienced a significant surge of 7% early on Thursday, following the announcement of encouraging data from a mid-stage…
Moderna Inc. Reports Narrower-Than-Expected Loss in Q2
1 Mins read
Moderna Inc. experienced a 5.5% rally in premarket trade on Thursday following the release of its second-quarter financial report. Although the company’s…